两市风格高低切换 南向资金持续流入

Group 1 - The market experienced a decline last Friday, with all three major indices closing lower and trading volume significantly shrinking to 2.32 trillion yuan, a decrease of 811.3 billion yuan from the previous trading day [1] - The energy metals, tourism, and photolithography sectors saw the highest gains, while robotics and industrial mother machines faced the largest declines [1] - The People's Bank of China announced a change in the 14-day reverse repurchase operation to fixed quantity and interest rate bidding, with the operation time and scale determined by liquidity management needs [1] Group 2 - The recent announcement from the National Healthcare Security Administration regarding the 11th batch of centralized drug procurement is noteworthy for pharmaceutical companies, emphasizing principles such as "stabilizing clinical use, ensuring quality, preventing collusion, and countering internal competition" [2] - The new procurement scheme optimizes the selection of price control anchors, moving away from simply choosing the lowest bid, and requires companies to justify their pricing against cost structures [2] - With the gradual improvement of anti-collusion measures in drug procurement, the pricing competition among pharmaceutical companies is expected to return to a healthier state, potentially enhancing their profitability [2]